UCSF study shows voriconazole increases risk for skin cancer in lung transplant recipients
A study conducted by researchers at the University of California San Francisco (UCSF) has showed that voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant patients, significantly increases the risk of skin can…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Fungal Infections | Lung Transplant | Pharmaceuticals | Skin | Skin Cancer | Study | Transplant Surgery | Transplants